AMPH
Price
$29.42
Change
+$0.23 (+0.79%)
Updated
Sep 5 closing price
Capitalization
1.37B
64 days until earnings call
MKKGY
Price
$25.77
Change
+$0.42 (+1.66%)
Updated
Sep 5 closing price
Capitalization
55.52B
68 days until earnings call
Interact to see
Advertisement

AMPH vs MKKGY

Header iconAMPH vs MKKGY Comparison
Open Charts AMPH vs MKKGYBanner chart's image
Amphastar Pharmaceuticals
Price$29.42
Change+$0.23 (+0.79%)
Volume$414.94K
Capitalization1.37B
Merck KGaA
Price$25.77
Change+$0.42 (+1.66%)
Volume$72.39K
Capitalization55.52B
AMPH vs MKKGY Comparison Chart in %
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. MKKGY commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Buy and MKKGY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (AMPH: $29.42 vs. MKKGY: $25.77)
Brand notoriety: AMPH and MKKGY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMPH: 78% vs. MKKGY: 51%
Market capitalization -- AMPH: $1.37B vs. MKKGY: $55.52B
AMPH [@Pharmaceuticals: Generic] is valued at $1.37B. MKKGY’s [@Pharmaceuticals: Generic] market capitalization is $55.52B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileMKKGY’s FA Score has 1 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • MKKGY’s FA Score: 1 green, 4 red.
According to our system of comparison, AMPH is a better buy in the long-term than MKKGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 5 TA indicator(s) are bullish while MKKGY’s TA Score has 2 bullish TA indicator(s).

  • AMPH’s TA Score: 5 bullish, 5 bearish.
  • MKKGY’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, AMPH is a better buy in the short-term than MKKGY.

Price Growth

AMPH (@Pharmaceuticals: Generic) experienced а -3.92% price change this week, while MKKGY (@Pharmaceuticals: Generic) price change was +1.38% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

AMPH is expected to report earnings on Nov 10, 2025.

MKKGY is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKKGY($55.5B) has a higher market cap than AMPH($1.37B). MKKGY has higher P/E ratio than AMPH: MKKGY (16.77) vs AMPH (11.02). MKKGY YTD gains are higher at: -8.380 vs. AMPH (-20.765). MKKGY has higher annual earnings (EBITDA): 5.87B vs. AMPH (248M). MKKGY has more cash in the bank: 1.57B vs. AMPH (232M). AMPH has less debt than MKKGY: AMPH (655M) vs MKKGY (9.4B). MKKGY has higher revenues than AMPH: MKKGY (21.2B) vs AMPH (723M).
AMPHMKKGYAMPH / MKKGY
Capitalization1.37B55.5B2%
EBITDA248M5.87B4%
Gain YTD-20.765-8.380248%
P/E Ratio11.0216.7766%
Revenue723M21.2B3%
Total Cash232M1.57B15%
Total Debt655M9.4B7%
FUNDAMENTALS RATINGS
AMPH vs MKKGY: Fundamental Ratings
AMPH
MKKGY
OUTLOOK RATING
1..100
366
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
8395
SMR RATING
1..100
4870
PRICE GROWTH RATING
1..100
4363
P/E GROWTH RATING
1..100
8091
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKKGY's Valuation (22) in the null industry is somewhat better than the same rating for AMPH (67) in the Pharmaceuticals Other industry. This means that MKKGY’s stock grew somewhat faster than AMPH’s over the last 12 months.

AMPH's Profit vs Risk Rating (83) in the Pharmaceuticals Other industry is in the same range as MKKGY (95) in the null industry. This means that AMPH’s stock grew similarly to MKKGY’s over the last 12 months.

AMPH's SMR Rating (48) in the Pharmaceuticals Other industry is in the same range as MKKGY (70) in the null industry. This means that AMPH’s stock grew similarly to MKKGY’s over the last 12 months.

AMPH's Price Growth Rating (43) in the Pharmaceuticals Other industry is in the same range as MKKGY (63) in the null industry. This means that AMPH’s stock grew similarly to MKKGY’s over the last 12 months.

AMPH's P/E Growth Rating (80) in the Pharmaceuticals Other industry is in the same range as MKKGY (91) in the null industry. This means that AMPH’s stock grew similarly to MKKGY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHMKKGY
RSI
ODDS (%)
Bearish Trend 2 days ago
64%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
54%
MACD
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
55%
Advances
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 18 days ago
60%
Declines
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 12 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
62%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNCY4.360.04
+0.93%
Unicycive Therapeutics Inc
JKHY162.240.95
+0.59%
Jack Henry & Associates
AVDX9.94N/A
N/A
AvidXchange Holdings
CARE19.50-0.09
-0.46%
Carter Bankshares
IVF0.82-0.02
-2.90%
INVO Fertility Inc

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with COLL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then COLL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
+0.79%
COLL - AMPH
39%
Loosely correlated
-2.32%
AMRX - AMPH
36%
Loosely correlated
+0.73%
ZTS - AMPH
33%
Poorly correlated
+0.08%
HROW - AMPH
31%
Poorly correlated
+2.18%
BHC - AMPH
30%
Poorly correlated
+1.94%
More

MKKGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKKGY
1D Price
Change %
MKKGY100%
+1.66%
MKGAF - MKKGY
49%
Loosely correlated
+1.49%
AMPH - MKKGY
25%
Poorly correlated
+0.79%
ZTS - MKKGY
25%
Poorly correlated
+0.08%
SUPN - MKKGY
25%
Poorly correlated
+1.25%
INDV - MKKGY
24%
Poorly correlated
+1.01%
More